Spain to participate in clinical trials of Johnson & Johnson coronavirus vaccine

The Spanish Agency for Medicine and Health Products (AEMPS) has authorized the first clinical trial in Spain of an experimental vaccine against the novel coronavirus. That’s according to Health Minister Salvador Illa, who made the announcement on Friday at a government press conference. The testing will involve a vaccine from Janssen, a company that is owned by the US multinational Johnson & Johnson, with 190 healthy volunteers from Spain. There will be a further 400 participants of the trial in Germany and Belgium. The recruitment of volunteers – who will be aged between 18 and 55, and over 65 – will begin “immediately,” Illa stated, with three Spanish hospitals – La Paz and La Princesa in Madrid, and Marqués de Valdecilla in Santander – taking part.